HRSA Launches PLOS Special Collection Highlighting Ryan White HIV/AIDS Program’s Innovative Models of Care
Blog updated 04/21/2021
Blog updated 04/21/2021
RWHAP Technical Assistance Provider updated on 03/05/2024
Resource updated 08/28/2023
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
In response to clinic operation curtailments during COVID-19 lockdowns, telehealth services have expanded across the nation.
Blog updated 01/17/2023
Resource updated 08/28/2023
Resource updated 09/19/2023
Resource updated 03/15/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
Successes and lessons learned will be shared from three metropolitan areas on incorporating STI testing and treatment for prevention clients within an HIV medical home setting, along with how offering STI treatment impacts early identification service outcomes (e.g., HIV positivity rates, linkage to care referrals, and the rapid start of HIV treatment).
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
This interactive workshop will review updated data and discuss implementation challenges, facilitators, and best practices for routine screening/linkage in an emergency department with urban and rural challenges. Preliminary data from the initial two months (with more than 2,000 patients screened) include .7% HIV (including three acute infections), 7% Hepatitis C (HCV) and 5.2% syphilis.
Resource (Conference Presentation) updated 09/14/2023
This session will highlight strategies to coordinate federal, state, and local funding streams to improve viral suppression for clients experiencing unstable housing. This is a panel session, and attendees will have the opportunity to share ideas, best practices, and roadblocks, and ask questions.
Resource (Conference Presentation) updated 09/14/2023
Sound monitoring practices require collaboration across an organization to implement strong financial and program management systems. The Texas Ryan White Part B program and fiscal monitoring units have developed robust processes and tools to share with other Ryan White recipients.
Resource (Conference Presentation) updated 09/14/2023
HRSA/HAB guidance on using RWHAP funds to provide services to eligible individuals in prisons, jails, and other correctional systems allows recipients to determine which RWHAP services to provide and for how long. This session will provide overviews of HAB policy and two recipients' programs serving people who are justice-involved.
Resource (Conference Presentation) updated 09/14/2023
Learn how small transformations in federal qualified health center (FQHC) practices can increase the rate of STI screening and treatment and eliminate barriers to care. Creating proficiency in scheduling patients by using urgent care appointments and implementing self-collection to empower patients and increase process efficiency can help patients receive needed services.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023